Shanghai RAAS finishes share buyback program

Shanghai RAAS Blood Products Co., Ltd. announced the completion of its share repurchase program on October 28, 2025. The company repurchased 69,081,952 shares, representing 1.04% of its total share capital, through centralized bidding on the secondary market between April 2, 2025, and October 28, 2025.

The total transaction value for the repurchased shares amounted to RMB 474,937,179.98, with prices ranging from a high of RMB 7.09 per share to a low of RMB 6.62 per share. The repurchases utilized the company's own funds and complied with the previously approved repurchase plan.

The repurchased shares are intended for employee stock ownership plans or equity incentives, with specific schemes yet to be announced. Shares not used for their intended purpose within 12 months will be canceled, reducing the registered capital.